Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy is a once-weekly injection, not a monthly one. The licensed schedule requires one dose every seven days throughout treatment, and taking it monthly — even during a difficult week or a holiday — would leave you significantly under-treated. Here is why the weekly rhythm matters, what happens if you miss a dose, and what the right clinical path looks like.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Wegovy injection schedule is weekly by design, not by convenience. Semaglutide's pharmacokinetics (the way it builds in the body) depend on a steady seven-day cycle. When you inject on the same day each week, blood levels stabilise between doses, keeping appetite suppression consistent. Miss a week and those levels drop in a way that often brings nausea and hunger back sharply when the next dose arrives.
The titration ladder starts at 0.25 mg, escalating through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance dose, with a minimum of around four weeks at each level. This is the schedule outlined in the NHS patient information for semaglutide, and it exists specifically to reduce gastrointestinal side effects during the adjustment period. Cutting the frequency to monthly would also disrupt that titration logic entirely. The dose steps are timed to the weekly rhythm; they are not interchangeable with longer gaps.
If you want a detailed overview of the treatment itself, the Wegovy treatment page covers eligibility, how it works and what to expect from start to finish.
Taking Wegovy monthly (12 injections a year instead of roughly 52) is not a lower dose. It is a different and unlicensed pattern that would produce inconsistent, inadequate semaglutide levels. Clinical trial results, including the STEP 1 study published in the New England Journal of Medicine, are based on weekly dosing over 68 weeks. The average weight reduction of around 15% observed in that trial has no equivalent evidence base at a once-monthly frequency.
Practically speaking: appetite regulation would likely be unreliable, with hunger returning sharply in the weeks between injections. Nausea might spike each time rather than settling into a manageable pattern. And because your prescriber sets each dose increase on the assumption of weekly injections, monthly dosing could look like a sudden large dose after a prolonged gap, not a gentle escalation.
There are common questions about short-term use, too. If you are wondering whether taking Wegovy for just one month is a realistic option, that question deserves a direct answer before you consider anything else. If you are wondering about taking Wegovy for a limited period, our page on what a three-month course of Wegovy involves covers that question directly. The short answer is that short courses are possible but require prescriber planning, and monthly dosing is not part of that conversation.
Most people asking this question are not planning to replace all 52 injections with 12. They are asking because life gets in the way: a fortnight abroad, a week where the timing feels wrong, or a delivery that slips to the wrong day. Those are reasonable concerns, and the good news is there is some genuine flexibility built into the licensed schedule.
If you miss your usual injection day, you can take it up to five days late and then return to your regular day as if nothing changed. If more than five days have passed, skip that week's dose and resume on your normal schedule the following week. The exact wording on this is in the Patient Information Leaflet, your prescriber can confirm what applies at your current dose.
On payday timing: if your treatment renews monthly and your injection day lands awkwardly, plan a day ahead. Once clinically approved, orders placed before 12pm on a working day are dispatched the same day via DPD and arrive the next working day. It is worth keeping that in mind when you are reordering, so you are never stretching the gap unnecessarily. If you have questions about keeping your supply consistent, understanding where to source Wegovy reliably in the UK is a useful starting point.
Any change to the dosing frequency (for any reason) is a clinical decision, not a personal one. This is not a bureaucratic nicety. Semaglutide is a prescription-only medicine, and the prescriber who assessed your suitability is also the right person to advise on what to do when circumstances change. NICE's appraisal of semaglutide for weight management sets out the framework under which it is recommended; that framework assumes the licensed weekly schedule.
At nume, a real clinician reviews your consultation and every repeat order before treatment is dispatched, it is never an automated process. If your situation has changed, our team can advise on what is appropriate. The eligibility and BMI criteria for Wegovy are also worth reviewing if you are new to treatment or considering whether it is the right fit for you. For broader questions about weight management options, our weight-loss treatment overview sets out what is available. And if eligibility is your first question before anything else, this guide on whether Wegovy is right for you is a sensible place to start. If you have specific concerns or your situation is complex, you can also reach us directly through our contact page.
Speak to our prescribers through a free consultation if you are unsure how your schedule should work or want to start treatment on the right footing.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.